Epilepsy

Valproic acid’s efficacy as a monotherapy is complicated by its previously demonstrated unsuitability for pregnant women.

Specific health-related quality of life measures in physical activities, well-being, cognition, and social activities were improved among those who underwent the laser ablation procedure.

The clinical fellow at Massachusetts General Hospital gives his call to action on how what needs to change to improve EEG education among residency programs.

Brian Wainger, MD, PhD, assistant professor of neurology and anesthesiology, Harvard Medical School, discussed the recently published phase 2 trial a repurposed epilepsy drug in patients with ALS.

The clinical fellow at Massachusetts General Hospital discussed the idea of standardizing the number of EEG reads residents should be required to do before their training is complete.

Veronica Hood, PhD, writes a recap of research and treatments for epilepsy presented at the meeting.

Here's what is coming soon to NeurologyLive.

The Dravet Syndrome Foundation offers a list of online resources for patient families.

A parent's perspective of the Partners Against Mortality in Epilepsy (PAME) 2020 meeting.

Physicians from Stanford Children’s Health offer their keys to successful pediatric neuroscience teams and what to focus on to provide a better quality of life for children.

The assistant professor of neurology and anesthesiology at Harvard Medical School discussed non-traditional ways ALS research is changing and where the focus should continue to be.

Neurology News Network for the week ending January 23, 2021.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 22, 2021.

The neurologist from the Comprehensive Epilepsy Care Center for Children and Adults, in St. Louis, Missouri, also discussed future studies planned for cenobamate.

The clinical fellow at Massachusetts General Hospital provided background on his efforts to raise awareness of inconsistencies with EEG education in neurology residency programs.

The calculation of fVPA based on this equation resulted in a misinterpretation in 40% of measurements with around 75% of them overestimating the actual measured fVPA.

The director of the Mid-Atlantic Epilepsy and Sleep Center discussed his team’s investigations into predicting responders and adverse events.

Including these agents for developmental and epileptic encephalopathies, the relatively young company has 5 programs under development to target rare neurological disorders.

A look into the numerous education series upcoming in 2021 by the Tuberous Sclerosis Alliance

The findings showed that 64% of EEG education programs did not utilize objective measures to assess EEG milestones.

Here's what is coming soon to NeurologyLive.

The neurologist from the Comprehensive Epilepsy Care Center for Children and Adults, in St. Louis, Missouri, discussed the different medications that cenobamate was used with.